GSTP1 and benign prostatic hyperplasia: Another three DMG panel (GSTP1, KIAA1539, and RNF219) assessed in a plasma collection (MSP coupled with bisulfite sequencing; PCa patients n = 20; BPH patients n = 17; HDs n = 18) showed that some CpGs within GSTP1 presented the highest performance for distinguishing PCa patients using plasma [29].